A monoclonal antibody linked to a toxic substance. It is being studied in the treatment of some types of B-cell cancer. CAT-8015 is made in the laboratory. It binds to CD22, a protein on the surface of normal B cells and B-cell tumors, and kills the cells. Also called anti-CD22 immunotoxin CAT-8015.